Concepedia

Anuj Patel

AP

Statistics

Publications

18

Citations

1K

H-Index

15

Active since

2018

Affiliations

Dana-Farber Cancer Institute(Current)

Massachusetts General Hospital

Harvard University

Yale Cancer Center

Brigham and Women's Hospital

Anuj Patel is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and gastrointestinal oncology.

Publications per year

2018–2026

18

Publications

18

Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine

Andrew J. Aguirre, Jonathan A. Nowak, Nicholas D. Camarda et al. · Cancer Discovery · 2018 · 369 citations · Full text

Medicine, Oncology, Dna Repair +10

A phase 2 trial of regorafenib as a single agent in patients with chemotherapy‐refractory, advanced, and metastatic biliary tract adenocarcinoma

Weijing Sun, Anuj Patel, Daniel P. Normolle et al. · Cancer · 2018 · 122 citations

Medicine, Oncology, Pharmacology +14

<i>FGFR2</i> Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma

James M. Cleary, Srivatsan Raghavan, Qibiao Wu et al. · Cancer Discovery · 2021 · 107 citations · Full text

Medicine, Molecular Genetics, Oncology +17

SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.

Rachna T. Shroff, Katherine A. Guthrie, Aaron J. Scott et al. · Journal of Clinical Oncology · 2023 · 99 citations

Medicine, Oncology, Pharmacology +9

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Rachna T. Shroff, Gentry Teng King, Sarah Colby et al. · Journal of Clinical Oncology · 2024 · 47 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 18